NCT00003466View on ClinicalTrials.gov

Temozolomide in Treating Patients With Progressive Low-Grade Glioma

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

temozolomide

Trial Locations (2)

27710

Duke Comprehensive Cancer Center, Durham

19104-4318

Children's Hospital of Philadelphia, Philadelphia

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER

NCT00003466 - Temozolomide in Treating Patients With Progressive Low-Grade Glioma | Biotech Hunter | Biotech Hunter